Tag: Competition

Displaying 201 - 220 of 2833 results.

Pages

Following a public comment period, the Federal Trade Commission has approved a final order resolving concerns that the acquisition of the Valspar Corporation by The Sherwin-Williams Company would likely allow the new company to exercise unilateral market power in the North American market for...
In testimony presented to the U.S. House of Representatives’ Judiciary Committee Subcommittee on Regulatory Reform, Commerical and Antitrust Law, the Federal Trade Commission described its efforts to stop anticompetitive conduct in the pharmaceutical industry.
WHAT:The U.S. Federal Trade Commission will host a Roundtable, Streamlining Licensing Across State Lines: Initiatives to Enhance Occupational License Portability. The event will explore options for enhancing the portability of occupational licenses.WHEN:Thursday, July 27, 2:00 p.m.–4:00 p.m.
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen released a summary of the agency’s major accomplishments since President Trump named her to the position in January. “I have pursued my long-held principles by promoting economic liberty, protecting consumers (including the military...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business would (1) reduce current competition in the United States for the...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business is anticompetitive.According to a complaint filed by...
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen announced today that she has selected D. Bruce Hoffman, a partner at the law firm of Shearman & Sterling LLP, to be the Acting Director of the FTC’s Bureau of Competition, effective August 7, 2017.
Federal Trade Commission staff submitted an additional public comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health Alliance and Wellmont Health System that would allow the two companies to merge.
Discussion of the significant negative effects on hospital prices, quality of care, and the availability of services likely to result from the merger of Mountain States and Wellmont, and of deficiencies in three reports filed by the applicants.
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen has appointed Neil Alan Chilson as the agency’s acting Chief Technologist.Chilson will be primarily responsible for advising Chairman Ohlhausen and the Commission on technology matters, including the FTC’s use of technology, technical...
Acting Federal Trade Commission Chairman Maureen K. Ohlhausen announced that FTC Bureau of Economics Director Ginger Zhe Jin is departing the agency to return to the University of Maryland and has named Michael G. Vita Acting Director of the Bureau.“Ginger was an outstanding Bureau Director,...
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. granting West Therapeutic Development, LLC certain rights to develop and market the specialty drug Synacthen Depot in the United States.Synacthen Depot contains a synthetic version of adrenocorticotropic...
Following a public comment period, the Federal Trade Commission has approved an application from LaFargeHolcim, Ltd to amend several agreements that were part of a 2015 FTC order settling charges that the $25 billion merger of Holcim Ltd. and Lafarge S.A. would likely harm competition in the United...

Pages